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ABSTRACT [D-Arg1, D-Trp5,7,9, Leu11] substance P (SPA) belongs to a family of peptides including antagonist G and SpD
that act as broad-spectrum neuropeptide antagonists at several peripheral receptors. The lipid-induced structure of these
peptides may be important for the receptor interactions of these analogs. Thus we describe the tertiary structure of SPA in the
presence of sodium dodecylsulfate micelles at pH 5.0, and 25C as determined from two-dimensional 1H-NMR data recorded at
500 MHz. The resulting three-dimensional structure can be generally described as two type IV nonstandard turns around Arg1*,
Pro2, Lys3, and Pro4 and Gln6, Trp7*, Phe8, and Trp9* residues, respectively, inserted into the interfacial region of the micelles
(the asterisks denote D-form amino acid). These turns juxtapose the N- and C-termini of SPA and may form the basis of this
peptide’s unique ability to inhibit peptide receptor interactions at multiple receptor types.
INTRODUCTION
Neuropeptides act as signals to regulate numerous physio-
logical functions centrally and peripherally via interactions
withG-protein coupled receptors (1). Thesemolecular messen-
gers are also potent growth factors for normal and cancerous
cells (2). For example, small cell lung cancer (SCLC) and
pancreatic cancer cells stimulate their own proliferation via
autocrine and paracrine actions of multiple peptide hormones
including; gastrin-releasing peptide, gastrin, cholecystoki-
nin, neurotensin, galanin, vasopressin, and bradykinin (2,3).
For this reason, therapeutic agents targeting one receptor
type cannot effectively suppress SCLC cell growth.
Broad-spectrum neuropeptide antagonists (BNSAs) are a
class of therapeutic compounds that address this multi-peptide
proliferative response by acting as antagonists at multiple
peptide-hormone receptors. For example, substance P analogs
(e.g., [Arg6, D-Trp7,9, NmePhe8] substance P(6-11) (antag-
onist G), [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P
(SpD), and [D-Arg1, D-Trp5,7,9, Leu11] substance P (SPA))
have been shown to inhibit the growth of SCLC cells in vivo
and in vitro (4,5). In initial studies, these broad-spectrum
neuropeptide antagonists were shown to be competitive in-
hibitors of the mitogenic neuropeptides at low micromolar
concentrations (4,6,7). Finally, a recent monograph has shown
that SPA attenuates tumor growth in pancreatic cancer via
antiproliferative and antiangiogenic mechanisms (8).
The molecular mechanisms for the inhibition of multiple
neuropeptide ligand/receptor interactions by substance P
analogs are unknown. Because these analogs act at multiple
receptors, one supposition is that these receptors share a
similar binding pocket for substance P analogs that overlaps
with the binding site for the native neuropeptide ligands.
Thus, the spatial arrangement of the substance P analog side
chain and backbone moieties that changes the pharmacology
of the neuropeptide receptors would be useful in the design
of future more high afﬁnity versions of the peptide.
Structural studies of several substance P analogs and
members of the substance P family of peptides have been per-
formed in aqueous and hydrophobic solutions by a variety
of methods. For example, [D-Arg1, D-Trp7,9]-SP, [D-Arg1,
D-Pro2, D-Trp7,9, Leu11]-SP, and [D-Pro2, D-Trp7,9]-SP have
been examined in aqueous solution and in the presence of
DMSO or hexaﬂuoroacetone (HFA) by circular dichroism
(CD) and NMR (9). Prabhu et al. concluded that these SP
analogs showed a ‘‘high’’ preference for b-turns in DMSO
and H2O while in HFA the C-terminal residues adopted a
helical conformation. The open question is whether or not
the solution conformation of an eleven amino acid peptide
can be stable enough in solution to measure a meaningful
tertiary structure. Furthermore is this solution state tertiary
structure the biologically active form of the peptide?
Ideally, one would obtain the structure of a peptide ligand
bound to its receptor. Unfortunately, for most G-protein
coupled receptors of pharmaceutical interest it is not possible
to measure the tertiary structure of the membrane bound
receptor or of the ligand/receptor complex. To our knowl-
edge, only one study has the reported structure of a peptide
agonist bound to a G-protein coupled receptor (10): Inooka
et al. determined the structure of a pituitary-adenylate-
cyclase-activating polypetide analog (PACAP(1-21)-NH2)
bound to the PACAP receptor. Their study required the
expression of milligram quantities of receptor, solubilization
of the receptor in digitonin, development of a ligand with
lowered afﬁnity for the receptor, and collection of NMR data
on an 800-MHz spectrometer (10). Therefore, because of the
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difﬁculty in obtaining ligand/receptor three-dimensional
(3D) structure, the structure of the ligand in solution in the
absence of receptor has been used for structure based-drug
design.
A less difﬁcult approach is to solve the tertiary structure of
the peptide ligand in the presence of lipid mimetics (11,12).
Previously, it has been proposed that the membrane surface
conformation and orientation of a peptide at a lipid bilayer
may be more important to the peptides afﬁnity and speciﬁcity
for a given receptor than its solution structure (13). In this
model a peptide may associate with the cell surface lipids by
insertion of hydrophobic residues, and electrostatic interac-
tions with charged lipid headgroups to form a unique 3D
conformation.
This lipid-induced conformation is transported via the
bilayer to its receptor-binding pocket located in a trans-
membrane portion of the receptor. If this model is correct the
lipid-induced tertiary structure of the peptide would be the
conformation that binds the receptor. This approach is lent
credence by the work on PACAP because these authors ob-
served that the lipid micelle bound structure and the receptor
bound structure of their PACAP analog shared a common
helical region (10). Therefore, in this work, we report the 3D
structure of the substance P analog, SPA, in the presence of
lipid micelles. Micelles made up of perdeuterated monomers
have the property of adding little proton background to the
spectra and enabling effective isotropic reorientation for bound
peptides. Other NMR methods show promise for elucidating
peptide structures in the presence of lipid vesicles, oriented
lipid bilayers, or lipid bicelles (e.g., (14) and references
therein).
Previously our laboratory has solved the micelles associ-
ated tertiary structure of SP (Arg-Pro-Lys-Pro-Gln-Gln-Phe-
Phe-Gly-Leu-Met-amide) in the presence of DPC and SDS
micelles and examined in detail the amide-exchange and
longitudinal (T1) and transverse (T2) relaxation time changes
upon micelle association (15,16). From these data a well-
characterized model of the orientation, dynamics, and ter-
tiary structure of substance P was developed (16). In this
model the N-terminal Arg-Pro-Lys-Pro- residues are located
above the micelle surface in a number of conformations, at
residue Gln5 or Gln6 the peptide is inserted in a nonstandard
turn containing the residues Phe-Phe-Gly and protected from
solvent exchange (the C-terminal residues are Leu10 and Leu11
are more exposed to amide exchange) (16). We postulated
that the structure of the Gln-Phe-Phe-Gly-Leu portion of
the peptide was an important recognition element for binding
to the NK-1 receptor. Similarly Auge’ et al. (14) using a
transfer NOE experiments in the presence of perdeuterated
DMPC (1,2-dimysteroyl-sn-glycero-3-phosphocholine-d72)
vesicles reported a substance P structure that consisted of
nonstandard turns in the C-terminus of the molecule. In
addition molecular dynamic calculations with substance P in
the presence of explicit SDS micelles in water showed that
substance P preferentially selects the lipid-water interface
and adopts a nonstandard turn structure for residues Gln-
Gln-Phe-Phe (17).
Few studies of the tertiary structures of substance P
analogs that act as antagonists at NK-type receptors have
been reported. Whitehead et al. reported that the [D-Pro2, D-
Phe7, D-Trp9]-SP and [D-Arg1, D-Pro2, D-Trp7, D-His9]-SP
had tertiary structures in the presence of SDS micelles that
consisted of a poorly deﬁned helical mid-region with a
b-turn in the C-terminal section of the peptide (18). These au-
thors suggest that the differences between the partial helical
nature of NK-A, NK-B, and substance P (NK-receptor ago-
nist peptides) and b-turn structures of the NK-receptor antag-
onists determine their biological activity.
The insertion of D-amino acids is known to disrupt helical
structures in solution and in the presence of lipid membranes
(e.g., (19,20)). Thus the presence of nonstandard turns in
D-amino acid substituted broad-spectrum-neuropeptide antag-
onists are to be expected. In this work we present the struc-
ture of another D-amino acid substituted substance P analog
(SPA) in the presence of SDS micelles for comparison with
those determined by Whitehead et al. (18).
MATERIALS AND METHODS
The SPA peptide was obtained from the UCLA Peptide Synthesis facility.
The peptides were puriﬁed by reverse phase HPLC. Analytical HPLC
showed their purity was above 90% and the correct sequence was veriﬁed by
mass spectrometry. The pH of the H2O solutions was adjusted to pH 5.0 by
the addition of HCl and NaOH; measurements were performed using an
Orion Model 601 pH meter ﬁtted with a combination electrode for 5 mm
NMR tubes (Ingold Electrodes, Wilmington, MA). The perdueterated d25-
SDS was purchased from C/D/N Isotopes (Pointe-Claire, Quebec, Canada)
and used in all the NMR experiments. Standard aqueous buffers were used
for electrode calibration at pH 4 and 7.
Circular dichroism and ﬂuorescence studies
CD studies were performed on a Jasco J-710 spectropolarimeter at 20C. A
sample of 80 mM SPA, 50 mM SDS, and a pH of 5.0 was freshly prepared
and the spectra acquired. Ten scans were averaged from 185 to 260 nm at a
rate of 100 nm/min. A 1-mm path length cell was used and the intensities are
expressed as molar ellipticity [u]222 (deg cm
2dmol1). The CD instrument
was calibrated using D-10 camphorsulphonic acid. The peptide concentra-
tion of the sample was prepared by dissolving weighed quantities of peptide
powder in SDS micelle solutions.
Fluorescence emission spectra were recorded on Photon Technology
Instrumental spectroﬂuorimeter (Monmouth Junction, NJ). The concentra-
tion of both NATA (N-acetyl tryptophan amide) and SPA were 40 mm
dissolved in 50 mM SDS in water at a pH of 5.0. Three scans were of the
emission spectra were recorded and averaged between 300 and 400 nm, at 1-
nm increments using 1 mm quartz cell with a scan speed of 100 nm/min at
room temperature for both NATA and SPA. The excitation wavelength was
ﬁxed at 280 nm with both excitation and the emission slit width set to 1 nm.
NMR studies
NMR experiments were performed on a Bruker 500 MHz spectrometer in
the City of Hope NMR facility with a 5 mm triple resonance xyz-gradient
probe and the air temperature regulated at 25C. Solutions for NMR analysis
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of SPA were made at;1 mM peptide concentration in 750 ml of 90% H2O/
10% D2O in water alone or 50 mM perdueterated SDS-micelle at pH 5.0.
Chemical shift assignments for SPA in solution were obtained by the
standard method using total correlation spectroscopy (TOCSY) (21), and
nuclear Overhauser effect spectroscopy (NOESY) (22) pulse sequences. All
chemical shifts were reference to external 2,2-dimethyl-2-silapentane-5-
sulfonic (DSS) acid in D2O.
Phase-sensitive NOESY data were collected for conformational analysis
of the SPA solutions with the Bruker library pulse program (23). A total of 8K
points were collected in t2 (64 transients per increment), a 100-ms or 200-ms
mixing time was used, and 480 complex points acquired in t1 using States-
TPPI (24,25). A relaxation delay of 1.5 s was used between transients. The
transmitter channel was used for excitation and observation of the 6000 Hz
proton frequency range. Water suppression was attained with a Watergate
sequence using ﬂip-back pulses with radiation damping suppression using
gradients in t1 (26). Data was processed with zero ﬁlling to 8K points in F2,
2K points in F1, and sinebell squared or Gaussian apodization functions in
both F1 and F2.
Phase-sensitive TOCSY spectra were collected to aid in the assignment
of SPA chemical shifts with the Bruker library pulse program (27). This
pulse sequence performs homonuclear Hartmann-Hahn transfer using a
DIPSI-2 sequence for mixing. Water suppression is performed using
excitation sculpting with gradients. A total of 8K points were collected in t2
(32 transients per increment), a 50-ms mixing time was used, and 480 points
were collected in t1 using States-TPPI. Data was processed with zero ﬁlling
to 8K points in F2, 2K points in F1, and sinebell squared or Gaussian
apodization functions in both F1 and F2.
NMR structure calculations
Structures for SPA were determined using XPLOR software, Version 3.1
(28). For SPA 100- and 200-ms NOESY experiments provided the 83
distance restraints needed for XPLOR 3D structure calculations. Distance
restraints were input as 1.8–6.0 A˚ distance ranges and standard pseudo-atom
corrections were used where appropriate (29). The constraint set for SPA
contained 25 intraresidue, 37 (i, i 1 1), 8 (i, i 1 2), 2 (i, i 1 3), 6 (i, i 1 4),
and 5 (3i, i15) NOEs between protons on various residues. The greater than
or equal to i, i1 5 NOEs can only be present in a stable folded conformation
of SPA.
These constraints were used for the calculation of SPA structures
satisfying the distance boundaries. One hundred and ﬁfty one embedded-
distance-geometry structures were obtained using the ‘‘sa’’ protocol with a
force constant of 50 kcal on the NOE-derived distance restraints. The LTOD
patch was used in the generate step of X-PLOR to get a coordinate ﬁle with
D-form Arg and Trp residues. The topallhdg.pro was modiﬁed to have the
D-form impropers. The parameter ﬁle ‘‘parallhdg.pro’’ was employed in this
procedure. Once structures were generated in this fashion, they were
subjected to an additional 10 ps of simulated annealing by the ‘‘reﬁne’’
protocol (28). Out of the resulting 45 structures with no distance violations
.0.3 A˚, 20 were chosen that had the lowest NOE energies. XPLOR
generated structures were visualized with the program Insight (Version
2000, Accelrys, San Diego, CA).
RESULTS
CD data
CD spectra from 190 to 260 nm are shown in Fig. 1 for SPA
in solution and for SPA in SDS micelles at pH 5.0 (the pH
where the NMR data was collected). The spectrum for SPA
in solution has two negative minima at 200 and 213 nm, a
positive maximum at around 229 nm. These spectral features
for SPA in aqueous solution at pH 5.0 could describe a
mixture of random coil ([]195–197 nm), b-turn (e.g.,
[1]190 and []213) conformers, and the contribution of the
tryptophan indole ring orientation with respect to the peptide
backbone ([1]229 nm) (30).
In the presence of SDS micelles a conformational shift in
SPA occurs compared to the structure in water alone (Fig. 1).
For SPA in the presence of micelles a broad minimum
around 200 nm and a sharper minimum 226 nm are ob-
served. The peak at 226 nanometers is characteristic of
tryptophan residues of which there are three in SPA (Trp5*,
Trp7*, and Trp9*). Woody has observed that because of the
low symmetry of the tryptophan side chain with respect to
rotation about the x2 bond (a dihedral formed by Cb and Cg
carbons) the sign of the 229-nm band can change markedly
with alterations in indole orientation (31). Upon association
with the SDS micelles the SPA indole moieties assume an
altered orientation with respect to the peptide backbone that
causes a major change in the sign of the ellipticity. If SPA
has a turn structure in the presence of micelles then these
features could be masked by the presence of this strong 226
nm ellipticity (32). Not observed are bands that would
indicate the presence of residues in a helical ([1]195,
[]208, and []222 nm), random coil ([]195–197 nm), or
beta-sheet ([1]195 and []215 to 217 nm) conformations.
A similar pattern of ellipticity was observed for SPA in the
presences of DPC micelles (data not shown).
Fluorescence data
We compared the ﬂuorescence of SPA in water alone or in
the presence of SDS micelles, with NATA (N-acetyl
FIGURE 1 Molecular ellipticity versus wavelength plots are shown for
solutions of 80 mM SPA. Spectra on samples in water alone or in the
presence of 50 mM SDS micelles at pH 5 and 20C are compared. The
change in the pattern of the spectra indicates association of the peptide with
the micelle with an alteration in the peptides conformation.
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tryptophan amide) to examine the effects of the different
solution conditions on the environment of the three trypto-
phan residues in SPA. The ﬂuorescence emission spectra
were recorded between 300 and 400 nm, at an excitation
wave length of 280 nm. The spectra were collected on
samples with 40 mM peptide or 40 mM NATA concentra-
tions in water or in solution with SDS micelles present at pH
5.0 and room temperature. In Fig. 2, SPA or NATA in water
have emission maximum of 348 and 352 nm, respectively. In
addition the SPA and NATA spectra in the presence of SDS
micelles have a shoulder not present in the NATA in water
only spectrum (at ;330–335 nms) suggesting this blue-
shifted shoulder is associated with the presence of the
micelles. In general when a peptide containing a ﬂuorescent
amino acid is inserted into a more hydrophobic environment
by associated with a lipid surface the wavelength of maximal
ﬂuorescence of the bound or folded species is blue-shifted
(e.g., from 350 nms to 325 nms) and an increase in intensity
is observed (33). By contrast, in the case of SPA association
with SDS micelles, although there is a small blue shift from
350 to 346 nm, a large decrease (42%) in intensity of the
signal relative to the value in water alone is observed. This
pattern has been attributed to location of the tryptophan
residues in the interfacial region of the lipid-water interface
(34). Thus the negative charge of the lipid headgroup alters
the ﬂuorescence quantum yield of the tryptophan either by a
direct quenching mechanism or indirectly by surface polarity
effects (dielectric) (35). Therefore the association of SPA
with SDS micelles results in the insertion of SPA tryptophan
residues into interfacial region of the water-micelle surface.
The intrinsic preferential localization of tryptophan contain-
ing peptides to the interfacial region of membrane surfaces
has been proposed before by Jacobs and White (36) and
tryptophan residues have been shown to found at the level of
the carbonyl group in phophatidylcholine membranes (37).
NMR data
Essentially complete chemical shift assignments were ob-
tained for SPA in aqueous solution alone and in the presence
of SDS micelles (Table 1). In addition ROE and NOE
intensity values were obtained for SPA in aqueous solution
and in the presence of SDS micelles, respectively. Because
no NOEs were observable for SPA in aqueous solution alone
(vtc ; 1) the ROESY pulse sequence was used to probe for
the presence of stable solution state tertiary structure in the
absence of lipids.
For SPA in aqueous solution sequential NH to NH ROEs
were observed in the 100-ms ROESY spectrum (not shown)
between residues on Gln6, Trp7*, Phe8, Trp9*, Leu10, and
Leu11 (the asterisks denote D-form amino acids). In addition,
sequential CaH to NH ROEs were observed for Gln6 to
Trp7*, Trp9* to Leu10, and Leu10 to Leu11 (data not shown).
Although several additional sequential backbone to side
chain and side chain to side chain ROEs were found, no
longer range ROEs were observed. These ROE interactions
suggest that the C-terminal portion of SPA folds into a con-
formation that is stable for the millisecond timescale neces-
sary to generate through-space magnetization transfer between
protons in the rotating-frame. However, the lack of longer
range ROEs suggests peptide conformational ﬂexibility in
solution.
The 1H-NMR signals observed for SPA in aqueous solu-
tion broaden and shift upon association with the slower
tumbling SDS micelles (Fig. 3). A single set of shifted proton
signals is observed indicating a unique stable lipid-associ-
ated form of the peptide. Similar spectra were observed for
the association of substance P with dodecylphosphocholine
(DPC) and SDS micelles (15,16). The partition coefﬁcient of
SP into anionic micelles has been reported to be ;102–106
M1 (14). Thus in the presence of an anionic micelle surface
under the solution conditions used in our studies, SP is
essentially completely bound. Because SPA is more hydro-
phobic than SP (containing three tryptophan residues), and
SP-like chemical shift changes are observed in SPA upon
titration with SDS we conclude that SPA is essentially com-
pletely bound to the SDS micelle surface under the con-
ditions used in this work.
The chemical shifts of SPA CaH protons in solution or in
the presence of SDS micelles minus the random-coil
solution-state chemical shifts of Wishart are plotted in Fig.
4, a and b, respectively (38). In water alone (Fig. 4 a)
signiﬁcant differences from random-coil values (.60.2
FIGURE 2 Fluorescence emission intensity versus wavelength plots are
shown for solutions of 40 mM SPA (solid line) or 40 mM NATA (dashed
line). A 280-nm excitation wavelength was used. Spectra in water alone or in
the presence of 50 mM SDS for both compounds are compared. The
observed decrease in ﬂuorescence intensity in the presence of the lipid
micelles is attributed to quenching caused by insertion of the tryptophan
indole rings into the hydrophobic lipid environment.
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ppm) are observed for residues Trp9* and Leu10. By contrast
shifts of SPA CaH protons in the presence of micelles (Fig. 4
b) show a different pattern and a greater than 0.2 ppm dif-
ference from random-coil values for residue Trp9*. For SPA
in water alone, the chemical shifts of the b, g, and d side-
chain protons of Leu10 are also signiﬁcantly shifted from
their random coil values by 0.64, 1.12, and 0.71 ppm,
respectively. The unusual water only chemical shifts for the
Leu10 side-chain protons are attributed to ring-current shifts
caused by the proximity of the Trp7*, Phe8, and Trp9*
aromatic rings. In addition, 3JNH-CaH scalar coupling con-
stants for SPA residues in solution ranged from 6 to 8 Hz
except for residues Trp7*and Trp9* that had values of 5.4 and
4.2 Hz, respectively. Consistent with the ROE data, these
chemical shift differences and coupling constant data suggest
a preference for a folded conformation in the Trp7*, Phe8,
Trp9*, Leu10 portion of SPA in water alone.
The chemical shifts of SPA NH and CaH protons in the
presence of SDS micelles minus their solution-state chemical
shifts are plotted in Fig. 4 c. Signiﬁcant differences are
observed for either the NH and/or CaH proton chemical shift
values of residues Trp5*, Gln6, Trp9*, and Leu10. These
chemical shift changes from the SPA solution-state values
indicate that these SPA residues associate with the SDS
micelle surface and concomitantly alter the environment of
the observed protons via changes in structure and/or inter-
action with lipid moieties.
The NOESY and TOCSY spectra acquired on solutions of
SPA in the presence of SDS micelles enabled structure
calculations to determine the tertiary structure of SPA in a
lipid environment (Fig. 5, a–c). A sequence of NH to NH con-
nectivities is observed in the 100-ms and 200-ms NOESY
spectra between residues Trp5* to Gln6 and Phe8 through
Leu11. The NH to NH connectivity between residues Gln6,
Trp7*, and Phe8 are obscured due to overlapping chemical
shift values. In addition, sequential NH to CaH NOEs were
observed for Trp5* to Gln6 and Trp9* to Leu11 (Fig. 6). The
NH to CaH NOEs between Gln6 and Trp9* are masked by
overlapping chemical shift values. Of note, there are signals
at the sites of Gln6 to Trp9* NH to CaH NOEs but they
cannot be unambiguously assigned. In contrast to SPA in
water alone, a number of long range NOEs were observed for
SPA in the presence of SDS micelles. For example, NOEs
are observed between Leu11 side-chain protons and Trp5*,
Trp7*, and Arg1* side-chain protons (Figs. 5 and 6). A list of
the observed i, i 1 2 and greater NOEs used in the structure
calculations is presented in Table 2.
X-PLOR structure calculations were based on a set of 83
NOEs derived from the 100-ms and 200-ms NOESY spectra
acquired on an aqueous solution of 1 mM SPA in 90% H2O/
TABLE 1 1H-NMR assignments for SPA in solution and in the presence of SDS micelles
NH CaH CbH CgH CdH Others
(D)Arg1* n.a. 4.36 1.91 1.68 3.23 dNH ¼ 7.25
(D)Arg1y n.a. n.a. 1.53 1.30 2.91 dNH ¼ 7.34
Pro2* n.a. 1.71/1.62 1.49/1.37 3.15/3.32
Pro2y 4.49 2.20/1.91 1.80 3.74/3.55
Lys3* 8.28 4.36 1.49/1.56 1.27 1.42 CeH ¼ 2.86/eNH3 ¼ n.a.
Lys3y 8.14 4.49 1.61/1.50 1.31 1.93/1.72 CeH ¼ 3.20/eNH3 ¼ 7.15
Pro4* 4.37 1.94/2.18 1.94 3.58/3.72
Pro4y 4.52 1.70/1.60 1.56/1.29 3.58/3.43
(D)Trp5* 7.15 4.52 3.21
2H-7.10 4H-7.52 5H-7.16
6H-7.22 7H-7.47 NH-10.09
(D)Trp5y 7.25 4.51 3.07
2H-6.94 4H-7.40 5H-6.96
6H-7.01 7H-7.28 NH-9.44
Gln6* 7.89 4.29 1.55/1.61 1.71 dNH2 ¼ 6.95/7.43
Gln6y 7.76 4.20 1.75 1.93 dNH2 ¼ 6.74/7.27
(D)Trp7* 8.38 4.44 3.03
2H-6.67 4H-7.56 5H-7.16
6H-7.22 7H-7.50 NH-10.20
(D)Trp7y 7.86 4.58 3.05/2.94
2H-7.12 4H-7.40 5H-7.01
6H-7.08 7H-7.38 NH-9.85
Phe8* 8.07 4.70 2.71/2.82 2,6H ¼ 6.96 3,5H ¼ 7.26 4H ¼ n.a.
Phe8y 7.76 4.56 2.98 2,6H ¼ 7.20 3,5H ¼ 7.10 4H ¼ n.a.
(D)Trp9* 7.92 4.14 2.47/2.97
2H-7.12 4H-7.52 5H-7.16
6H-7.25 7H-7.43 NH-10.09
(D)Trp9y 8.24 4.31 3.17/3.06
2H-7.14 4H-7.49 5H-7.03
6H-7.12 7H-7.64 NH-10.06
Leu10* 7.97 3.72 1.01/1.15 0.52 0.23/0.33
Leu10y 6.78 4.00 1.42 1.24 0.60/0.52
Leu11* 7.82 4.16 1.55/1.64 n.a. 0.77/0.86 NH2 ¼ 6.67/7.13
Leu11y 7.83 4.21 1.69 1.54 0.83/0.75 NH2 ¼ 6.84/7.06
n.a. ¼ not assigned; residues 1,5,7, and 9 are D-form amino acids.
*1 mM SPA in 90% H2O/10% D2O; pH ¼ 5.0.
ySPA in SDS micelles (1:50) in 90% H2O/10% D2O; pH ¼ 5.0.
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10% D2O at pH 5.0 with 50 mM SDS monomer present. The
distance constraint set was provided as input to the X-PLOR
program. One hundred and ﬁfty-one initial structures were
generated by the simulated annealing protocol and further
reﬁned by molecular dynamics and energy minimization (see
Materials and Methods). An overlay was produced of the 20
best structures that had the lowest NOE energies from a set of
45 structures that had no NOE violations .0.3 A˚. Fig. 7 a
depicts a stereo-view of the backbone (NH, CaH, CO)
overlay and Fig. 7 b shows the stereo-view of the heavy atom
overlay of six structures (NH, CaH, CO, and side-chain
carbon, oxygen, and nitrogen). The calculated structure root-
mean-square deviations (RMSDs) are 0.78 6 0.24 for the
backbone atoms and 1.30 6 0.33 A˚ for the heavy atom
overlays of residues 1–11 for 20 structures. Fig. 8 shows the
backbone (circles) and heavy atom (squares) RMSDs per
residue for the overlay of 20 structures. The error bars in Fig.
8 denote the range of deviations from the mean structure for
each residue of a 10-structure ensemble. Residue Gln6 is the
least precisely deﬁned residue for both side-chain and
backbone atoms. The use of distance constraints from 1.8 to
6 A´˚ for all the observed NOEs in the NMR data preferentially
selects structures that comply with the longer distance
constraints and deemphasizes the importance of shorter i to
i 1 1 constraints. This method selects the folded conforma-
FIGURE 3 A plot of the 6.5–8.9 ppm frequency range of the 500MHz 1D
1H-NMR spectra of 1 mM SPA in the presence of 50 mM SDS micelles (a)
or in water alone (b). Selected amide proton signals are labeled with their
assigned residues. The broadened and shifted amide proton signals are
characteristic of association of the peptide with the larger molecular weight
slower tumbling micelles.
FIGURE 4 Chemical shift difference plots for SPA protons in water alone
or in the presence of SDS micelles. The CaH chemical shift differences of
SPA protons in water alone (a) or in the presence of SDS micelles (b) minus
the random coil chemical shifts of Wishart et al. (51), respectively, are
shown. A plot of the chemical shift differences of the identical NH and CaH
protons from SPA in the presence of SDS micelles minus the chemical shifts
of SPA in aqueous solution (c) is also shown. Shift differences.60.2 ppm
indicate a signiﬁcant change in the chemical environment of the proton when
going from aqueous to lipid milieus.
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tions deﬁned by the majority of the NOE derived distance
constraints and puts less emphasis in the structure calcula-
tions on the larger NOE volumes observed in the spectra.
After the structure calculations were completed we applied
the programs PROCHECK_NMR and AQUA to the analysis
of the NOE derived distance restraints and the structure of
SPA (39). For the 83 constraints, 18 intraresidue distance
restraints were found to be unnecessary by the AQUA
criteria. The remaining 65 intraresidue distance restraints and
the sequential, medium, and long-range interresidue con-
straints were all found to be nonredundant by the AQUA
analysis. Two restraints were excluded by AQUA because
they arose from the side chain amino protons of Lys3 which
normally are not visible in the spectra due to solvent
exchange. In the presence of SDS micelles the exchange rate
is slowed sufﬁciently that they are observable in the NOESY
spectra and we observe crosspeaks to Pro2 and Pro4 side-
chain protons to these protons.
The AQUA completeness score for SPA is 13% with the
best deﬁned portion of the peptide found in the C-terminal
residues Trp9* and Leu10 (completeness 20–25%). For the
N-terminal portion of the peptide residues Lys3, Pro4, and Trp5*
have completeness scores of 10–15%. The Ramachandran
analysis shows that all of the L-form amino acids in averaged
SPA structure of 10 or 20 calculated structures are in allowed
regions for their f-c angles (not shown). As expected for
D-form amino acids, thef-c plots of the individually overlayed
structures mostly show Trp5*, Trp7*, and Trp9* in disallowed
or generously allowed regions.
Finally, an examination of other 3D structure studies of
similarly sized peptides reveals that the number of restraints
we report here is very similar to literature values (e.g., (14,
15,18)). As short peptides are by their nature less proton
dense than longer peptides or proteins fewer NOEs are
observable. However, the presence of the long range NOE
crosspeaks is unequivocal and our calculated structure
represents a conformation that satisﬁes the complete set of
83 distance restraints without violation of a single distance
bounds by the XPLOR criteria.
DISCUSSION
The interaction of a gastrointestinal peptide with lipid
membranes may be important for its bioactivity in a number
FIGURE 5 Selected regions of 500-
MHz two-dimensional (2D) 1H-NMR
spectra of SPA in the presence of SDS
micelles, including: (a) the NH proton
to CaH proton correlation region of a
200-ms 2D NOESY spectrum, (b) the
NH proton to CaH, CbH, CgH, and
CdH proton correlation region of a 50-
ms 2D TOCSY spectrum, (c) the NH
proton to CaH, CbH, CgH, and CdH
proton correlation region of a 200-ms
2D NOESY spectrum. Selected cross-
peaks are labeled. All spectra were
acquired on a solution of 1 mM SPA at
pH 5.0 with 50 mM SDS and 25C in
90% H2O/10% D2O.
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of steps from synthesis to action at a target receptor. In this
work we examine the last step in this process where some
have theorized that lipids in the membrane mediate the trans-
port of peptides toward their receptors and the 3D confor-
mation of the peptide that binds and activates the receptor
(13). There is speciﬁc evidence that gastrin (40) and CCK
(41,42) molecular forms interact with the CCK-B receptor
via such a lipid-associated mechanism.
The work of Moroder and co-workers showed that gastrin
and cholecystokinin fragments retained their ability to bind
the CCK-B receptor with their N-termini anchored to the
lipid bilayer by conjugation with lipid tails (40). Therefore,
because lipo-derivatized gastrin and cholecystokinin bind to
the CCK-B receptor with similar afﬁnities and have primary
sequence homology they may assume a common lipid-
associated conformation that interacts with the same residues
of the CCK-B receptor. In addition, as SPA is a competitive
inhibitor of these peptides at the CCK-B receptor the lipid-
associated conformation reported in this work could share a
common spatial organization of peptide side chains that
enables inhibition of CCK-B receptor binding by gastrin and
cholecystokinin.
SPA in water
The CD, ﬂuorescence, and NMR spectra for SPA in aqueous
solution alone indicate a partially folded structure (Figs. 1–4).
The CD spectra for SPA in water show a combination of
random coil and turn-like features. The ﬂuorescence spectra
show that in water alone with equivalent concentrations of
NATA and SPA, the NATA signal intensity is two-thirds
that of SPA, which contains three tryptophan residues. Thus
SPA in water alone must have a folded structure that affects
the quantum yield of one or more the tryptophan residues.
The NMR chemical shift data show residues with large
changes from their random coil values for residues Trp7*,
Trp9*, and Leu10.
SPA in lipid
The CD, ﬂuorescence, and NMR chemical shift data
collected on SPA in the presence of SDS micelles show a
major shift in tertiary structure compared to water alone.
SPA binds to the lipid surface and alters the orientation of
one or more of the three tryptophan side chains (Fig. 1) and
alters the ﬂuorescence of the indole rings (Fig. 2) compared
to the structure in water alone. Of note the ﬂuorescence
spectrum of SPA in the presence of SDS micelles closely
resembles that of NATA in the presence of SDS micelles
instead of being one-third of the intensity. Based on com-
parisons to literature data we conclude that the tryptophan
side chains are inserted into the water-lipid headgroup inter-
facial region of the SDS micelles (34–37).
The SPA chemical shift values in the presence of SDS
micelles may be compared to Wishart random coil chemical
shift values (Fig. 4; (38)). Selective chemical shift value
changes are observed throughout the peptide in the presence
of SDS micelles compared to their random coil chemical
shift values. The largest changes are observed for Leu10 NH
and Trp5* backbone and side-chain NH values (1.38,
1.00, and 0.76 ppm, respectively, dSDS-dRC). Other
interesting large shifts from random coil values are observed
for Pro4 b and g protons, the Trp7* side-chain NH proton,
and the backbone amide protons of Gln6, Trp7*, and Phe8.
The differences between both random coil and water only
chemical shift values supports the conclusion that SPA has
at least a partially folded structure in water alone and that
this fold is altered with micelles association.
NMR structure determination
The BSNA SPA in the presence of SDS micelles folds into a
unique tertiary structure that brings the N- and C-terminal
FIGURE 6 Selected NOE connectivity data used in the calculation of the
tertiary structure of SPA in the presence of SDS micelles. The intensity of
the bar classiﬁes the NOE as a strong, medium, or weak signal. The clover
symbol denotes connectivity that was not observed because of chemical shift
degeneracy.
TABLE 2 Table of i,i 1 2 and longer NOEs used in the structure calculations
i, i 1 2 i, i 1 3 i, i 1 4 $ i, i 1 5
P4 Hd Q6 HN R1 HE P4 Hd K3 HN W7 Hb* R1 HE Q6 Ha
W5 Ha W7 HN Q6 HN W9 Hb* W7 HH2 L11 Hb* W5 HD1 L11 Hd*
W5 Ha W7 HE1 W7 HH2 L11 Hd* P4 Hd* W9 HH2
W9 HD1 L11 Hd* W7 HE1 K3 Hg*
W9 HD1 L11 Hg* R1 HE W5 Ha
F8 HD* L11 HN W7 HH2 L11 Hg*
W7 HD1 W9 HE1
Lipid-Induced Tertiary Structure of SPA 4485
Biophysical Journal 91(12) 4478–4489
arginine and leucine residues near in space. This fold is stable
enough for the observation of intermolecular NOEs and
chemical shift perturbations. The long range NOEs in Table 2
and the other NOEs observed in 100- and 200-ms NOESY
data were used to calculate the structure observed in Fig. 7.
The compact structure can be loosely described as two
nonstandard (Type IV) turns created by residues Arg1*
through Pro4, a connecting residue Trp5* and a second turn
from Gln6 to Trp9* (Fig. 7). These turns are called non
standard because the mean angles derived over 20 structures
do not fall into standard turn geometries, including; Type I
(most common, 60, 30, and 90, 0 degree; f-c angles
for residues 2 and 3 of the turn) or Type III (helical, 60,
30, and 60, 30). The mean and standard deviation for
the f-c angles of 20 calculated structures for Pro2 and Lys3
are 76 6 6, 59 6 35, and 90 6 32, 174 6 13 degrees.
The mean and standard deviation for thef-c angles of 20 cal-
culated structures for Trp7* and Phe8 are916 72,486 66,
and 144 6 86, 56 6 28.
The precision of the overlay indicates the tertiary structure
of the backbone for residues Arg1 to Leu11 are well deﬁned
with the orientation of the side chains established best for
Pro2, Pro4, Phe8, and Trp9* (Fig. 8). The position of residue
Qln6, which is central to the structure of the peptide and the
N-terminal residue Arg1* are less well deﬁned by NOE dis-
tance constraints compared to neighboring residues. There-
fore although the structural data presented is fully consistent
with the CD, NMR, and ﬂuorescence data we cannot exclude
the presence of other conformers that result from conforma-
tional ﬂexibility at the N-terminus and at Gln6.
Ring current effects
The accuracy of the calculated structure is supported by the
ring current shifts observed for the side-chain protons in the
vicinity of the Trp5*, Trp7*, Phe8, and Trp9* residues. Ring
currents arise from the diamagnetic anisotropy of the aro-
matic rings and are often the major contributing factor to the
observed conformation-dependent chemical shifts of side-
chain protons (43). In general those protons oriented perpen-
dicular to the face of the aromatic ring or in the plane of the
ring will be shifted signiﬁcantly upﬁeld (#0.2 ppm) or
downﬁeld ($10.2 ppm), respectively, compared to their
random coil chemical shift values when they are within four
to ﬁve angstroms of the aromatic ring.
The chemical shift values of SPA in the presence of SDS
micelles can be compared to the water only (WO) SPA
chemical shift values determined in this work to assess
changes that occur with micelle association. Based on the
calculated structure residue Trp5* ring currents cause sig-
niﬁcant upﬁeld shifts of protons on Arg1* (b, g, and d proton
chemical shift values from 0.32 to 0.38 ppm, relative to
the WO chemical shift values in Table 1, dSDS-dWO). Trp
5*
along with Trp7* inﬂuence the resonance position of Pro4
(WO b and g shifts from 0.24 to 0.65 ppm) protons.
Trp7* ring currents shift downﬁeld the side-chain protons of
Lys3 (WO d and e shifts from 10.30 to 10.51 ppm). Ring
current effects are particularly noticeable for the Leu10
backbone NH proton that shifts11.19 ppm from the solution
state value (attributed to the proximity of Phe8 and Trp9*).
FIGURE 7 Stereo-views of the superposition of 20 coordinate sets of the
backbone atoms (a) and six heavy atom coordinate sets (b) derived from 45
X-PLOR calculated structures derived from SPA proton NOE connectivity
data observed in the presence of SDS micelles. Coordinate sets with no NOE
violations .0.3 A˚ and the lowest NOE energies were selected for these
overlays.
FIGURE 8 A plot of the RMSD per residue for the backbone (open
squares) and heavy atom (solid circles) overlay of the 20 backbone or 20
heavy atom X-PLOR-calculated structures. The error bars denote the range
of deviations from the mean structure for each residue of the 10 structure
ensembles.
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In addition, Leu10 side-chain CgH and CdH protons are
shifted downﬁeld by 10.72 and 10.37 ppm, respectively,
from their water alone values. Residues Gln6 and Leu11
chemical shift values are largely free of changes with micelle
association.
The chemical shift differences between the peptide inwater
alone and in the presence of SDSmicelles show large changes
for Trp7*, Phe8, Trp9*, and Leu10 (Fig. 4 c). These data
suggest that the partially folded structure in aqueous solution
binds the SDS micelles with an insertion of Trp7*, Phe8,
Trp9*, and Leu10 residues into the water-micelle interface.
SPA has different water-only and lipid-associated struc-
tures than substance P. For SPA, the differences in the CaH
proton shifts from their random coil values indicates that
residues Trp9*, and Leu10 of SPA have a nonrandom coil-
like structure in water only (Fig. 4 a). This view is supported
by the CD data (Fig. 1). By contrast, substance P (Arg-Pro-
Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2) water only
NMR and CD data indicated a random coil solution structure
(15). A direct comparison of structure perturbation upon
lipid binding is the chemical shift differences of the identical
peptide backbone amide and CaH protons between the
solution and lipid associated states (Fig. 4 c). For SPA, these
data show signiﬁcant shifts in Trp7*, Phe8, Trp9*, and Leu10
residues and smaller perturbations of the amino terminal
Arg1*, Pro2, Lys3, Pro4, Trp5*, Gln6 residues upon lipid
binding. By contrast, substance P shows signiﬁcant shifts at
Lys3 and Gln5-Met11 (15). A common element between sub-
stance P and SPA structures is the presence of C-terminal
nonstandard turn structures while where they differ is in the
N-terminal and mid-region structure.
Whitehead et al. found that D-amino acid substituted
antagonists of the NK-1 receptor [D-Pro2, D-Phe7, D-Trp9]-
SP and [D-Arg1, D-Pro2, D-Trp7, D-His9]-SP had poorly
deﬁned helical mid-regions followed by a nonstandard
b-turn structure at their C-termini (18). By contrast the tertiary
structures of the NK receptor agonists—substance P, NKA
and NKB—determined by Whitehead et al. in the presence
of SDS micelles under identical conditions had helical
regions that extended to residue 9 or 10. These authors
conclude that the C-terminal nonstandard b-turn (containing
residues 7, 8, and 9) enables antagonism at the NK-1 receptor.
Therefore, in this context, the structure of the BNSA SPA
([D-Arg1, D-Trp5,7,9, Leu11] substance P) determined in this
work that contains a turn structure including residues 7, 8,
and 9, is consistent with the model of Whitehead et al. in
spite of the sequence differences between these peptides. By
contrast the helical mid-regions of [D-Pro2, D-Phe7,
D-Trp9]-SP and [D-Arg1, D-Pro2, D-Trp7, D-His9]-SP are
replaced by a nonstandard turn in the N-terminus of SPA.
We propose that the substitution of D-amino acids and the
presence of Trp5* in particular leads to the unique series of
two nonstandard turns that enable this peptide to act as an
antagonists at not only the NK1 receptor but also the brady-
kinin, vasopressin, GRP, bombesin, and gastrin receptors (7).
Based on the NMR chemical shift values observed in this
work and comparisons to the previously determined detailed
model of substance P/SDS micelle association we propose
that C-terminus of SPA inserts into the water-lipid interface
via residues Trp7*, Phe8, Trp9*, and Leu10. Where SPA
differs from substance P and the other substance P analogs is
in the N-terminal turn structure. In the presence of SDS
micelles a well-deﬁned nonstandard turn is formed consist-
ing of Arg1*, Pro2, Lys3, and Pro4. We propose that the
charged side chains of Arg1* and/or Lys3 form salt bridges
with sulfate headgroups and the hydrophobic segments of
these residues and those of the neighboring proline amino
acids act to stabilize a well-deﬁned turn structure in SPA.
Evidence for the interaction of Lys3 amino group with sulfate
headgroups is the observation of the side chain eNH3 signal
in the spectra collected in the presence of SDS micelles but
not in the water alone spectra.
SPA ([D-Arg1, D-Trp5,7,9, Leu11] substance P) inhibits the
activity of a number of G-protein coupled neuropeptide
receptors, including: bradykinin, vasopressin, gastrin-releas-
ing peptide (GRP), bombesin, and gastrin receptors (44–46).
By contrast, spantide ([D-Arg1, D-Trp7,9, Leu11] substance P)
has been shown to be a NK1, NK2, and bombesin receptor
antagonists but does not inhibit the activity of cholecysto-
kinin, gastrin, or secretin peptides (47–49). Spantide only
differs from SPA by the substitution of a D-Trp for Gln at
position 5.
The position 5 substitution alters the tertiary structure of
SPA compared to spantide in water alone and in the presence
of SDS micelles. Bello et al. showed CD spectra for spantide
in 0.1 M phosphate buffer at pH 7 that show []200 and
[]225 nm bands (50). In our pH 5 water alone spectra we
observed []200, []213, and [1]229 nm bands. For
spantide in 40 mM SDS and pH 6.8, Di Bello et al. observe
[1]190, []200, and []226 nm bands with the ratio of the
[]200 to []226 band intensities being 0.8. In this work at
pH 5.0 and 50 mM SDS no [1]190 nm band was observed
and the relative ratios of the []200:[]226 nm intensities
was 0.4.
The ﬂuorescence spectrum of spantide in aqueous solution
does not change signiﬁcantly upon addition of SDS micelles
and displays emission maxima of ;337 nms and similar
broad peak shape for both solution conditions. By contrast,
for SPA there is a 42% decrease in the observed intensity
with the addition of SDS micelles with minimal shift in the
observed maxima. We conclude that the structures of SPA
and spantide in SDS micelles are different because of the
substitution of a D-Trp for Gln at position 5 and that these
unique conformations play a role in the altered receptor
pharmacology observed for these two substance P analogs.
CONCLUSIONS
Because SPA is a competitive inhibitor of mitogenic peptide
hormones such as bombesin, cholecystokinin, and gastrin,
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the receptor bound conformation of SPA and these ligands
could have a region of tertiary structure identity that interacts
at a similar receptor binding site. Thus the 3D conformation
of SPA in the presence of lipids may represent the spatial
arrangement of functional groups found in the receptor
bound state of the peptide. If so this conformation would be
useful in the design of nonpeptide antagonists and agonists
for the treatment of pancreatic, colon, and prostate cancers.
The use of lipid associated structures of peptide ligands for
design of analogs active at G-protein coupled receptors is
limited in that receptor-ligand interactions are not directly
interrogated. The value of the structures determined to date
will become apparent when sufﬁcient receptor and appro-
priate methods to reconstitute them in their biologically
active receptor associated form become available for detailed
NMR studies (e.g., (10)).
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